Forest Clinical Trials Registry Launches With Antidepressant Data
This article was originally published in The Pink Sheet Daily
Executive Summary
Forest's registry website, required under a settlement with the New York Attorney General, currently includes summaries of pediatric and adolescent studies of Lexapro and Celexa, and listings for all of Forest's open Phase III and IV trials.